Welcome to the "Did You Know?" Twist Bioscience Video Series

Hear how the power of Twist Bioscience is enabling researchers with synthetic biology solutions for studying genetic variations and functional consequences, as well as helping advance fields of research including genetics, medicine, biotechnology, and drug discovery.

Learn more in 1 minute

Did you know that tumor evolution is a significant problem for drug developers?

Learn how Twist is helping drug developers characterize and catalog mutations in KRAS through large-scale saturation mutagenesis screens. 

Read More

Did you know that ionic charge can affect antibody-target binding?

Learn how Twist helped a leading pharmaceutical company precisely interrogate key residues involved in both target recognition and antibody charge by synthesizing combinatorial variant libraries.

Read More

Did you know that CAR-T cell therapy requires multiple levels of protein engineering?

Learn how Twist enabled researchers to narrow in on better, more effective CAR constructs for cell therapy through large scale synthesis and testing of more than 8000 CAR constructs with each differing in variant domain combinations.

Read More

Did you know that between 1981 and 2019, antibodies and other biologics represented approximately 17% of the new drugs that entered the US market?

Learn how Twist helped relieve the biologics bottleneck caused by the low-throughput, resource-intensive process of designing, synthesizing, and characterizing antibody variants in the discovery pipeline with our gene to protein workflow which results in antibodies ready for screening.

Read More